Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 369 for “"clostridium difficile"”.
-
Reducing Clostridium Difficile
… to reduce the number of laboratory identified Clostridium Difficile Infections (CDI) events by 20% by December 2015. This CNL projects focuses on reducing CDI in an 8 unit bed specifically designated for medically ill geriatric patients above 70 years old residing in the West Texas region. A …
-
Reducing Hospital-Acquired Clostridium Difficile
… This project focused on implementation of clostridium difficile (C. diff) education sessions at Hospital A, a not-for-profit, short-term, acute care hospital serving the Greater Sacramento community. It comprises of 241 staffed beds in the medical-surgical, telemetry, and intensive care …
-
PREVENTION OF CLOSTRIDIUM DIFFICILE INFECTION
Clostridium difficile infection (CDI) prevention is of high priority. We reviewed clinical practice guidelines (CPGs), and conducted an individual participant data meta-analysis (IPMDA) of randomized controlled trials (RCTs) to assess effectiveness and safety of probiotic prophylaxis. For CPGs, we …
-
Clostridium difficile and its toxins
An investigation of Clostridium difficile has shown : 1. that the organism is resistant to cresols and phenolq and may be grown from material grossly contaminated with other organisms by culture in media containing these substances; strains isolated before this method was evised are also resistant …
-
Clostridium difficile Toxins: Entry and Uptake
Clostridium difficile is a major nosocomial pathogen that causes hospital-acquired and antibiotic-associated diarrhea through the actions of two related exotoxins (TcdA and TcdB) on the host. They are large, multi-domain toxins that enter cells by receptor-mediated endocytosis. Upon acidification, …
-
Clostridium difficile transcriptomics and metronidazole resistance
… have been associated with increased risk of C. difficile infections and increased toxin production when combined with antimicrobial therapy. The first part of this project involved characterization of a hypervirulent NAP1 C. difficile strain, including genome sequencing and assembly, and the …
-
Hospital Acquired Clostridium Difficile Infection Prevention
Abstract The aim of my CNL Internship Project is to decrease the incidence of healthcare acquired C diff infections at the acute care unit 1800 to zero for the next quarter. This will be accomplished by developing an action plan to address the issue by collecting data from audits and developing …
-
Clostridium-difficile-Infektion nach herzchirurgischem Eingriff
Clostridium difficile ist einer der führenden Nosokomialkeime in Bezug auf postoperative Diarrhoe. Die Inzidenz ist steigend und der Verlauf bei fulminanter Infektion häufig fatal. Es besteht der Anspruch der Vermeidung schwerer Verläufe und der horizontalen Verbreitung des Erregers. Ziel der …
-
Comparative proteomic analysis of Clostridium difficile
… has led to extensive analysis of the genome of Clostridium difficile. In contrast, protein expression analysis, crucial to the elucidation of mechanisms of disease, has severely lagged behind. In this study, in-depth proteomic analysis of three strains of varying virulence, demonstrated …
-
Phenotypic and genotypic characterisation of Clostridium Difficile
Clostridium difficile is at present one of the most common nosocomial infections in the developed world. Hypervirulent strains (PCR ribotype 027) of C. difficile which produce enhanced levels of toxins have also been associated with other characteristics such as a greater rate of sporulation and …
-
The Economic Burden of Clostridium difficile infection
Clostridium difficile infection (CDI) leads to significant burden on the healthcare system (e.g., lengthy hospital stay, readmissions). The economic impact associated with CDI in Canada is poorly understood, as only three studies have quantified the burden with results primarily based on expert …
-
Clostridium difficile Mannan and Campylobacter jejuni Heptan
Clostridium difficile infection in humans is on the rise and vaccine targets that will reduce both disease and colonization levels are needed. Potential vaccines comprised of C. difficile cell-wall polysaccharides PS-I, PS-II, and PS-III are being investigated in the Monteiro laboratory at Guelph. …
-
Recombinant antibodies against Clostridium difficile toxin A
Clostridium difficile is a major cause of nosocomial intestinal infection. The pathogen possesses two potent toxins, Toxin A and Toxin B, both of which contribute to diarrhoea, intestinal inflammation and tissue damage. Antibiotics are effective against the disease, however around 20 % of patients …
-
Recombinant antibodies against Clostridium difficile toxin A
The carboxy-terminal region of Clostridium difficile Toxin A was expressed as a recombinant protein (ToxinA-CT), purified, and shown to behave as would be expected of the receptor-binding domain. ToxinA-CT was then used to isolate scFv antibodies from a phage display library using conventional …
-
Exploiting Bacteriophages to Tackle Clostridium difficile Infection
Clostridium difficile infection (CDI) currently affects around 20,000 people each year, in healthcare institutions and in the community, and will often follow disruption of the gut microbiome. Current treatment strategies call for the use of further antibiotics, of which there is a limited choice. …
-
Characterisation of Antibiotic Resistance in Clostridium difficile
Abstract Clostridium difficile is a Gram-positive, obligate anaerobe and an opportunistic pathogen that causes antibiotic associated diarrhoea. The incidence of C. difficile infection (CDI) increased dramatically in the early years of this century, an epidemic caused by the previously rare ribotype …
Page 1 of 19